Taiwan drug authorities issued their second drug recall within a week for use of lower-grade ingredients in over-the-counter drugs, this time targeting 23 products of 19 Taiwan companies.
As with the earlier recall, the Taiwan FDA said drugmakers used food-grade magnesium carbonate or industrial-grade calcium carbonate as active pharmaceutical ingredients in the medicines. Drug producers are required to use pharmaceutical-grade APIs.
The agency said the companies could be fined close to $100,000 for each infraction. The 23 drugs cited were for treating stomach ailments.
A week earlier, the TFDA ordered a recall of 23 other drugs made by 13 companies that contained the same ingredients.